Condition: Immune-related Adverse Event · Dietary Habits · Sponsor: Universitair Ziekenhuis Brussel
The FORX (Food intervention to Reduce immunotherapy toXicity) trial will assess whether supplementing dietary fiber intake by providing weekly boxes containing 30 different plants to patients with solid tumors starting immune checkpoint inhibitor therapy affects the incidence of immune related adverse events.
This description comes directly from the study's public registry record.
Marthe Verhaert, MD · +3224749480 · marthe.verhaert@uzbrussel.be
Sandrine Aspeslagh, MD PhD · sandrine.aspeslagh@uzbrussel.be
Always discuss trial participation with your own doctor first.
| UZ Brussel | Jette, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05832606